| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Liver Cirrhosis, Experimental | D008106 | 36 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
20-HETE
20-hete is a lipid of Fatty Acyls (FA) class. 20-hete is associated with abnormalities such as Cyst, Kidney Diseases, Kidney Failure, Chronic, Cystic Kidney Diseases and Simple renal cyst. The involved functions are known as Phosphorylation, inhibitors, Hypertrophy, Epithelial Cell Proliferation and Anabolism. 20-hete often locates in Mouse Kidney, Microsomes, Tissue membrane, Body tissue and Cytoplasmic matrix. The associated genes with 20-HETE are CYP4F3 gene, PKHD1 gene, Transgenes, P4HTM gene and CYP2E1 gene. The related lipids are Promega, enterodiol, Fatty Acids, hexanoic acid and U 73343. The related experimental models are Mouse Model, Knock-out, Streptozotocin Diabetes, Transgenic Model and Rodent Model.
Cross Reference
Introduction
To understand associated biological information of 20-HETE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 20-HETE?
20-HETE is suspected in Hypertensive disease, Renal tubular disorder, endothelial dysfunction, Renal glomerular disease, Ischemia, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Hypertension (27)
- Am. J. Physiol. Heart Circ. Physiol. (19)
- Am. J. Physiol. Regul. Integr. Comp. Physiol. (16)
- Others (110)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 20-HETE
PubChem Associated disorders and diseases
What pathways are associated with 20-HETE
Lipid pathways are not clear in current pathway databases. We organized associated pathways with 20-HETE through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
- Am. J. Physiol. Heart Circ. Physiol. (16)
- Hypertension (14)
- Am. J. Physiol. Renal Physiol. (10)
- Others (63)
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 20-HETE?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Hypertension (28)
- Am. J. Physiol. Heart Circ. Physiol. (26)
- Am. J. Physiol. Regul. Integr. Comp. Physiol. (18)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 20-HETE?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 20-HETE?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 20-HETE?
Related references are published most in these journals:
- Hypertension (20)
- Am. J. Physiol. Heart Circ. Physiol. (19)
- Am. J. Physiol. Regul. Integr. Comp. Physiol. (12)
- Others (86)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 20-HETE?
Mouse Model
Mouse Model are used in the study '20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.' (Park F et al., 2008), Mouse Model are used in the study 'Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.' (Alexanian A et al., 2009) and Mouse Model are used in the study 'Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.' (Harder DR and Roman RJ, 2006).
Knock-out
Knock-out are used in the study 'Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle.' (Yu M et al., 2007) and Knock-out are used in the study 'Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.' (Williams JM et al., 2007).
Streptozotocin Diabetes
Streptozotocin Diabetes are used in the study 'Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.' (Chen YJ et al., 2008).
Related references are published most in these journals:
- Am. J. Physiol. Regul. Integr. Comp. Physiol. (2)
- J. Am. Soc. Nephrol. (2)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Others (4)
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with 20-HETE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ito O et al. | Expression of cytochrome P-450 4 enzymes in the kidney and liver: regulation by PPAR and species-difference between rat and human. | 2006 | Mol. Cell. Biochem. | pmid:16552476 |
| Poloyac SM et al. | Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia. | 2006 | J. Cereb. Blood Flow Metab. | pmid:16570075 |
| Omura T et al. | Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. | 2006 | Stroke | pmid:16601220 |
| Harder DR and Roman RJ | Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. | 2006 | Circ. Res. | pmid:16614311 |
| Joly E et al. | Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE. | 2006 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:16675634 |
| Chen Y et al. | Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. | 2006 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:16679377 |
| Jacobs ER et al. | VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase. | 2006 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:16679379 |
| Ward NC et al. | 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans. | 2006 | Diabetes Res. Clin. Pract. | pmid:16713008 |
| Hacein-Bey L et al. | Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage. | 2006 Jun-Jul | AJNR Am J Neuroradiol | pmid:16775295 |
| Fang X et al. | 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. | 2006 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16782846 |
| Harmon SD et al. | Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production. | 2006 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:16820285 |
| Blanton A et al. | Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. | 2006 | J. Hypertens. | pmid:16915037 |
| Escalante B et al. | Cytochrome P450-dependent arachidonic acid metabolites, 19- and 20-hydroxyeicosatetraenoic acids, enhance sodium-potassium ATPase activity in vascular smooth muscle. | 1990 | J. Cardiovasc. Pharmacol. | pmid:1700215 |
| Sankaralingam S et al. | Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats. | 2006 | Am. J. Hypertens. | pmid:17070431 |
| Elijovich F | 20-HETE and salt-sensitivity of blood pressure a novel emerging concept. | 2006 | Am. J. Hypertens. | pmid:17070432 |
| Marvar PJ et al. | High dietary salt reduces the contribution of 20-HETE to arteriolar oxygen responsiveness in skeletal muscle. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17114243 |
| Zhang JH | Editorial: experimental subarachnoid hemorrhage second issue: cerebral vasospasm. | 2006 | Neurol. Res. | pmid:17164031 |
| Roman RJ et al. | Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. | 2006 | Neurol. Res. | pmid:17164037 |
| Fang X et al. | 20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma. | 2007 | Prostaglandins Other Lipid Mediat. | pmid:17164145 |
| Guo AM et al. | Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17210799 |
| Williams JM et al. | Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis. | 2007 | Hypertension | pmid:17210834 |
| Kuczeriszka M et al. | Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats. | 2006 | J. Physiol. Pharmacol. | pmid:17244949 |
| Kirchheimer C et al. | Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule. | 2007 | Am. J. Physiol. Renal Physiol. | pmid:17264308 |
| Snider NT et al. | Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17272674 |
| Yu M et al. | Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle. | 2007 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:17303679 |
| Stec DE et al. | 20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells. | 2007 | Cell. Physiol. Biochem. | pmid:17310106 |
| Carroll MA et al. | Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. | 1992 | J. Pharmacol. Exp. Ther. | pmid:1731035 |
| Stec DE et al. | Functional polymorphism in human CYP4F2 decreases 20-HETE production. | 2007 | Physiol. Genomics | pmid:17341693 |
| Ng VY et al. | Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. | 2007 | Drug Metab. Dispos. | pmid:17431031 |
| Barden A et al. | A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. | 2007 | Free Radic. Biol. Med. | pmid:17462541 |
| Williams JM et al. | Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. | 2007 | Am. J. Physiol. Renal Physiol. | pmid:17507602 |
| Roman RJ and Lombard JH | Does 20-hydroxyeicosatetraenoic acid contribute to sex differences in cardiovascular risk by increasing oxidative stress? | 2007 | Hypertension | pmid:17548717 |
| Singh H et al. | Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. | 2007 | Hypertension | pmid:17548721 |
| Chábová VC et al. | Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. | 2007 Aug-Sep | Vascul. Pharmacol. | pmid:17604232 |
| Zhang D et al. | [Roles of 20-HETE on physiologic and pathologic regulation in organism]. | 2007 | Sheng Li Ke Xue Jin Zhan | pmid:17633224 |
| Morin C et al. | Functional effects of 20-HETE on human bronchi: hyperpolarization and relaxation due to BKCa channel activation. | 2007 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:17660330 |
| Capdevila JH | Regulation of ion transport and blood pressure by cytochrome p450 monooxygenases. | 2007 | Curr. Opin. Nephrol. Hypertens. | pmid:17693763 |
| Wang MZ et al. | Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine. | 2007 | Drug Metab. Dispos. | pmid:17709372 |
| CertÃková Chábová V et al. | The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats. | 2007 | Kidney Blood Press. Res. | pmid:17785988 |
| Yousif MH and Benter IF | Role of cytochrome P450 metabolites of arachidonic acid in regulation of corporal smooth muscle tone in diabetic and older rats. | 2007 Nov-Dec | Vascul. Pharmacol. | pmid:17855173 |
| Gebremedhin D et al. | Role of 20-HETE in the hypoxia-induced activation of Ca2+-activated K+ channel currents in rat cerebral arterial muscle cells. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17906097 |
| Liang CJ et al. | 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta. | 2008 | J. Lipid Res. | pmid:17916879 |
| Tanaka Y et al. | Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats. | 2007 | Neurosci. Res. | pmid:17933409 |
| Ishizuka T et al. | 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells. | 2008 | J. Pharmacol. Exp. Ther. | pmid:17947496 |
| Schubert GA and Thome C | Cerebral blood flow changes in acute subarachnoid hemorrhage. | 2008 | Front. Biosci. | pmid:17981651 |
| Jerez S et al. | Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites. | 2008 | Eur. J. Pharmacol. | pmid:18053983 |
| Zhang Y et al. | Arachidonic acid metabolism in glucocorticoid-induced hypertension. | 2008 | Clin. Exp. Pharmacol. Physiol. | pmid:18067589 |
| Cheng J et al. | 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18156192 |
| Nilakantan V et al. | 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. | 2008 | Am. J. Physiol. Renal Physiol. | pmid:18171997 |
| Morin C et al. | Effects of omega-hydroxylase product on distal human pulmonary arteries. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18203846 |
| Laffer CL et al. | The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. | 2008 | Hypertension | pmid:18227405 |
| Koehler RC et al. | Insensitivity of cerebral oxygen transport to oxygen affinity of hemoglobin-based oxygen carriers. | 2008 | Biochim. Biophys. Acta | pmid:18230370 |
| Liu H et al. | Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension. | 2008 | J. Am. Soc. Nephrol. | pmid:18235092 |
| Singh H and Schwartzman ML | Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension. | 2008 Jan-Feb | Pharmacol Rep | pmid:18276983 |
| Medhora M et al. | 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. | 2008 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:18296498 |
| Tunctan B et al. | A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. | 2008 | Shock | pmid:18323740 |
| Chen YJ et al. | Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18326808 |
| Berezan DJ et al. | Aging increases cytochrome P450 4A modulation of alpha1-adrenergic vasoconstriction in mesenteric arteries. | 2008 | J. Cardiovasc. Pharmacol. | pmid:18356699 |
| Gao Z et al. | 20-HETE increases renal sympathetic nerve activity via activation of chemically and mechanically sensitive muscle afferents. | 2008 | J. Physiol. (Lond.) | pmid:18372304 |
| Minuz P et al. | Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. | 2008 | Hypertension | pmid:18378855 |
| Ward NC et al. | A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. | 2008 | Hypertension | pmid:18391101 |
| Wang Z et al. | 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. | 2008 | Eur. J. Pharmacol. | pmid:18455723 |
| Fu Z et al. | Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject. | 2008 | Endocrine | pmid:18484194 |
| Liu X et al. | Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18502903 |
| Antoun J et al. | CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. | 2008 | J. Lipid Res. | pmid:18566475 |
| Fava C et al. | The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. | 2008 | Hypertension | pmid:18574070 |
| Lai CK et al. | Effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid on tracheobronchial clearance in normal human airways. | 1991 | Thorax | pmid:1858085 |
| Guo AM et al. | Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18591218 |
| Park F et al. | 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. | 2008 | J. Am. Soc. Nephrol. | pmid:18596124 |
| Zhou Y et al. | Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. | 2008 | Kidney Int. | pmid:18596730 |
| Mu Y et al. | Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation. | 2008 | Drug Metab. Dispos. | pmid:18725506 |
| Lv X et al. | Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. | 2008 | Eur. J. Pharmacol. | pmid:18771665 |
| Rimmerman N et al. | Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors. | 2009 | Prostaglandins Other Lipid Mediat. | pmid:18812233 |
| Williams JM et al. | Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury. | 2008 | Am. J. Physiol. Renal Physiol. | pmid:18842817 |
| Dunn KM et al. | Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18952718 |
| Yang HY and Chen JR | Renoprotective effects of soy protein hydrolysates in N(omega)-nitro-L-arginine methyl ester hydrochloride-induced hypertensive rats. | 2008 | Hypertens. Res. | pmid:18957819 |
| Tsai IJ et al. | 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. | 2009 | Free Radic. Biol. Med. | pmid:19013235 |
| Regner KR et al. | Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. | 2009 | Kidney Int. | pmid:19052533 |
| Abraham NG et al. | Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid. | 1991 | Blood | pmid:1909194 |
| Renic M et al. | Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. | 2009 | J. Cereb. Blood Flow Metab. | pmid:19107134 |
| Nayeem MA et al. | High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases. | 2009 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:19109366 |
| Park F et al. | Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:19129252 |
| Luo P et al. | Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:19129258 |
| Dhanasekaran A et al. | 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19136601 |
| Dołegowska B et al. | Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report. | 2009 | Transpl. Int. | pmid:19175563 |
| Eid AA et al. | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 2009 | Diabetes | pmid:19208908 |
| Wang J et al. | Modulation of vascular O2 responses by cytochrome 450-4A omega-hydroxylase metabolites in Dahl salt-sensitive rats. | 2009 | Microcirculation | pmid:19225982 |
| Hamilton SJ et al. | Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. | 2009 | Diabetes Care | pmid:19228872 |
| Cao S et al. | Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion. | 2009 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:19261918 |
| Kompanowska-Jezierska E and Kuczeriszka M | Cytochrome P-450 metabolites in renal circulation and excretion--interaction with the nitric oxide (NO) system. | 2008 | J. Physiol. Pharmacol. | pmid:19261977 |
| Liu X et al. | Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. | 2009 | Kidney Int. | pmid:19279555 |
| Schwartzman ML et al. | Detection of 20-hydroxyeicosatetraenoic acid in rat urine. | 1991 | Biochem. Biophys. Res. Commun. | pmid:1930236 |
| Yousif MH et al. | Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. | 2009 | Auton Autacoid Pharmacol | pmid:19302551 |
| Yousif MH et al. | Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. | 2009 | Auton Autacoid Pharmacol | pmid:19302554 |
| Hilgers RH and De Mey JG | Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1. | 2009 | Br. J. Pharmacol. | pmid:19302591 |
| Inoue R et al. | Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways. | 2009 | Circ. Res. | pmid:19443836 |
| Zhang Y et al. | The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension. | 2009 | J. Hypertens. | pmid:19458537 |
| Cai Y | Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model?? | 2009 | Kidney Int. | pmid:19483747 |
| Guo AM et al. | 20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19502554 |
| Akbulut T et al. | 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:19570883 |